Hypothalamic Neuropeptide 26RFa Acts as an Incretin to Regulate Glucose Homeostasis
Open Access
- 9 April 2015
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 64 (8) , 2805-2816
Abstract
26RFa is a hypothalamic neuropeptide that promotes food intake. 26RFa is upregulated in obese animal models, and its orexigenic activity is accentuated in rodents fed a high-fat diet, suggesting that this neuropeptide might play a role in the development and maintenance of the obese status. As obesity is frequently associated with type 2 diabetes, we investigated whether 26RFa may be involved in the regulation of glucose homeostasis. In the current study, we show a moderate positive correlation between plasma 26RFa levels and plasma insulin in patients with diabetes. Plasma 26RFa concentration also increases in response to an oral glucose tolerance test. In addition, we found that 26RFa and its receptor GPR103 are present in human pancreatic β-cells as well as in the gut. In mice, 26RFa attenuates the hyperglycemia induced by a glucose load, potentiates insulin sensitivity, and increases plasma insulin concentrations. Consistent with these data, 26RFa stimulates insulin production by MIN6 insulinoma cells. Finally, we show, using in vivo and in vitro approaches, that a glucose load induces a massive secretion of 26RFa by the small intestine. Altogether, the present data indicate that 26RFa acts as an incretin to regulate glucose homeostasis.Keywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale (U982)
- Conseil Régional de Haute-Normandie (U982)
- Plateforme Régionale de Recherche en Imagerie Cellulaire de Haute-Normandie (U982)
- Institute for Research and Innovation in Biomedecine (U982)
This publication has 33 references indexed in Scilit:
- The RFamide neuropeptide 26RFa and its role in the control of neuroendocrine functionsFrontiers in Neuroendocrinology, 2011
- Apelin is necessary for the maintenance of insulin sensitivityAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- CRFR1 is expressed on pancreatic β cells, promotes β cell proliferation, and potentiates insulin secretion in a glucose-dependent mannerProceedings of the National Academy of Sciences, 2009
- Central administration of the RFamide peptides, QRFP-26 and QRFP-43, increases high fat food intake in ratsPeptides, 2008
- Distribution of 26RFa binding sites and GPR103 mRNA in the central nervous system of the ratJournal of Comparative Neurology, 2007
- 26RFa, a novel orexigenic neuropeptide, inhibits insulin secretion in the rat pancreasPeptides, 2007
- Anatomical distribution and biochemical characterization of the novel RFamide peptide 26RFa in the human hypothalamus and spinal cordJournal of Neurochemistry, 2006
- Islet cell failure in type 2 diabetesJournal of Clinical Investigation, 2006
- A neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, behavioral arousal, and blood pressure in miceProceedings of the National Academy of Sciences, 2006
- Identification and Characterization of a Novel RF-amide Peptide Ligand for Orphan G-protein-coupled Receptor SP9155Journal of Biological Chemistry, 2003